ArticleScientific reports2025
Genomic analysis of Inonotus hispidus provides insights into its medicinal properties and evolutionary dynamics.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bipolar, not tetrapolar: mating system determination in Inonotus hispidus through genomic and phenotypic analysis.Applied microbiology and biotechnology · 2026Article
- Integrated metabolomics and computational analysis suggest that aFrontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Inonotus hispidus, a fungal species morphologically closely related to the medicinal genus Sanghuang,has garned considerable attention due to its potential health-prompting benefits. This study presents the whole-genome sequence of I. hispidus ZA-14, a monokaryotic strain isolated from wild fruiting bodies growing in Morus alba (hereinafter referred to as MA). The 37.68 Mb genome was assembled from 5771 Mb of raw data, resulting in 51 contigs with a GC content of 48.48%. A total of 8924 protein-coding genes were predicted, with 223 non-coding RNAs identified. The genome analysis revealed a high density of genes associated with secondary metabolite biosynthesis, including those involved in terpenoid, polysaccharide, and flavonoid pathways-key contributors to its medicinal attributes. Comparative genomic analysis with other related fungal species provided insights into the evolutionary dynamics and speciation of I. hispidus. The study also identified a significant enrichment of glycoside hydrolase family genes, suggesting a critical role in nutrient absorption and utilization. These findings enhance our understanding of the genetic basis of I. hispidus's medicinal value and its evolutionary relationships, providing a foundation for future breeding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.